MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 24.88
+0.76 (3.15%)
Aug 21, 2026, 5:35 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €893.48 million as of August 21, 2026. Its market cap has increased by 52.00% in one year.
Market Cap
893.48M
Enterprise Value
880.57M
Revenue
24.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
€24.88
ChartMarket Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 893.48M, an increase of 511.53%. That is a compound annual growth rate of 25.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 893.48M | 7.11% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 9.52B |
| Nanobiotix | 1.93B |
| Inventiva | 949.85M |
| DBV Technologies | 739.20M |
| Genfit | 721.35M |
| Valneva SE | 562.49M |
| Valerio Therapeutics Société anonyme | 424.53M |
| Transgene | 221.30M |